Navigation Links
Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway

o discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA approved product to use this nab platform, ABRAXANE(R), was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on The Nasdaq Global Market under the symbol ABBI. For more information about the company and its products, please visit www.abraxisbio.com.

FORWARD-LOOKING STATEMENT

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the timing and scope of clinical studies and trials for nab-rapamycin mTOR inhibitor (ABI 009), and nab-17AAG HSP90 inhibitor (ABI 010). Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the fact that results from pre-clinical studies may not be predictive of results to be obtained in other pre-clinical studies and future clinical trials, delays in commencement and completion of clinical trials, including slower than anticipated patient enrollment and adverse events occurring during the clinical trials, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the availability and pricing of ingredients used in the manufacture of pharmaceutical products, the ability to successfully manufacture products in a time-sensitive and cost effective manner, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties. Additional
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Abraxis BioScience Presents Results from Pre-Clinical Study That Demonstrates nab-Rapamycins Robust Antitumor Properties and Ability to Target Intracellular Sites Such as the mTOR Pathway
2. Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
5. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
9. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
10. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
11. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
Post Your Comments:
(Date:7/22/2014)... /PRNewswire-iReach/ -- Reproductive Medicine Associates of New York ... a nationally and internationally-recognized leader in providing exceptional quality ... pleased to announce a new collaboration with EMD Serono ... recognize the sacrifices made by veterans and their families ... will allow qualifying veterans and the spouses of veterans ...
(Date:7/22/2014)... , July 22, 2014 BioDelivery Sciences ... that its Board of Directors has appointed Charles ... Feinberg as members of the Board.  ... with extensive experience in marketing, sales and other commercial ... Pearl Therapeutics, Inc., a development stage company that was ...
(Date:7/22/2014)... , July 22, 2014  NeuroSigma, Inc. (NeuroSigma), a ... on commercialization of its non-invasive Monarch ™ ... neuropsychiatric disorders, today announced that enrollment has begun in ... stimulation (eTNS) as adjunctive therapy for the treatment of ... conducted at the Olive View-UCLA Medical Center in ...
Breaking Medicine Technology:Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 2Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 4BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 6BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 7Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5
(Date:7/23/2014)... Online medical service provider MeMD has appointed Dr. Nicholas ... Lorenzo joins the MeMD executive team with over 25 years ... of this remote treatment model, telemedicine. This is the type ... school, that someday we could treat people across the country. ... it hasn't been that long,” says Dr. Lorenzo. , After ...
(Date:7/23/2014)... 2014 Previously, the crew members for Maplewood’s ... spreadsheet. Now, the department’s 53 part-time members “self-schedule” ... Management system. , “Scheduling our personnel with paper and pencil, ... to keep track of when people could work, because they ... this time, and we would have to try to figure ...
(Date:7/22/2014)... 2014 Men and women who are ... portion of their disposable income each year on different ... its best anti aging products guide to help introduce ... guide is now released and accessible from any tablet, ... retailers were selected and inserted into the guide to ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 St. ... of the newest component of its existing telemedicine program- ... within the regional SSM Health Care of Oklahoma network. ... centers that shares its services with an even wider ... centers across several states. As a forward-thinking organization looking ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 DocbookMD ... process of deploying one of the largest physician-centric mobile ... ( MHMD ) in Houston. , Created by Austin-based ... the DocbookMD application will be embedded into MHMD’s Accountable ... searched for the best technology to put this capability ...
Breaking Medicine News(10 mins):Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 2Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 3Health News:This Fire Department Allows Personnel to Schedule Themselves - Saving Administration Up To 60 Hours a Month 2Health News:This Fire Department Allows Personnel to Schedule Themselves - Saving Administration Up To 60 Hours a Month 3Health News:Best Anti Aging Products Guide Launched for Natural Product Buyers Online at News Portal 2Health News:St. Anthony Hospital Expands Its Telemedicine Program with Telepsychiatry 2Health News:St. Anthony Hospital Expands Its Telemedicine Program with Telepsychiatry 3Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 3Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 4
... UHC and Novation for Outstanding Service-NAPERVILLE, Ill., April 22 ... healthcare industry,s leading contracting services company, announced today ... OMX ), a leader in office products and ... Excellence Supplier Award most notably as Supplier of the ...
... a large study, a national team of researchers led ... hormone therapy was associated with a significantly lower colorectal ... association are still unclear. , The study, being presented ... to look at possible links between estrogen exposure and ...
... by Lucy Selman and colleagues from King,s College London, ... their family carers in sub-Saharan Africa often do not ... management, which impacts negatively on their ability to cope ... published online by the BMJ today. , ...
... Promoting Health and Wellness and Reducing Common and Costly ... Group Says to Senate and House LeadershipWASHINGTON, April 22 ... Fight Chronic Disease (PFCD) - an organization representing some ... today called on leaders in Congress to encourage updates ...
... in Heidelberg, Germany and its Scientific Director, anatomist Dr. Gunther ... BODY WORLDS and KORPERWELTEN - categorically ... with or affiliated to OUR BODY, the display in Paris ... its doors to the public.In the last twenty four hours, ...
... impact of metabolic syndrome on mortality in hepatitis C ... presented on Sunday April 26 at EASL 2009, the ... of the Liver in Copenhagen, Denmark. , According to ... obesity and hypertension (HTN) are associated with overall and ...
Cached Medicine News:Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 2Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 3Health News:Hormone therapy offers potential protective effect against colon cancer in older women 2Health News:Palliative care skills training needed for health-care staff in sub-Saharan Africa 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 3Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 4Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 5Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 6Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 7Health News:Gunther Von Hagens' BODY WORLDS and KORPERWELTEN - Not Affiliated With Paris Copycat Display 2Health News:Diabetes, obesity and hypertension increase mortality in hepatitis C patients 2Health News:Diabetes, obesity and hypertension increase mortality in hepatitis C patients 3
... the typical patient, right for the not-so-typical ... you have the ability to address the ... least expect themeven after implant. St. Jude ... to be prepared in almost any situation, ...
... The R4Mplus offers global companies a ... meet RFID compliance initiatives. With die-cast ... variety of connectivity options, and complex ... a super value. Plus, the fully ...
... combines enhanced memory, processing capacity, ... reliable all-metal construction. Proven platform ... print speed make it the ... value reliability, productivity, consistent print ...
... companies a cost-effective and dependable performer ... With die-cast metal construction, centralized printer/encoder ... and complex multi-language font support, the ... the fully integrated RFID reader/encoder supports ...
Medicine Products: